Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2015 | Recent developments in targeted therapies for chronic lymphocytic leukemia

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Jacqueline Barrientos, MD, of the North Shore-LIJ Cancer Institute, Lake Success, NY, provides a summary of recent developments in new therapeutic options for patients with chronic lymphocytic leukemia (CLL), including those with known complications, such as the presence of 17p deletion.